Lung India
Scope & Guideline
Transforming respiratory healthcare with every publication.
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal publishes original research articles focused on various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and COVID-19. This research often involves clinical trials, observational studies, and case reports that contribute to the understanding of disease mechanisms and patient care. - Innovative Diagnostic Techniques:
Lung India emphasizes the importance of novel diagnostic methodologies, such as endobronchial ultrasound, imaging techniques, and biomarkers, to improve the accuracy of lung disease diagnosis and management. - Public Health and Epidemiology:
The journal addresses public health issues related to lung diseases, including the epidemiology of respiratory conditions in specific populations, the impact of environmental factors, and strategies for disease prevention and health promotion. - Management Guidelines and Consensus Statements:
The publication frequently features guidelines and consensus statements developed by expert panels to standardize treatment approaches for various lung diseases, ensuring that clinicians have access to the latest recommendations. - Interventional Pulmonology:
Research related to minimally invasive procedures and therapies in pulmonary medicine, including bronchoscopy and thoracoscopy, is a key area of focus, highlighting advancements in patient care.
Trending and Emerging
- COVID-19 Research and Sequelae:
The impact of COVID-19 on lung health has become a dominant theme, with numerous studies addressing acute management, long-term sequelae, and the implications for patients with pre-existing respiratory conditions. - Telemedicine and Remote Monitoring:
The rise of telemedicine as a vital tool for managing respiratory diseases has gained traction, particularly during the pandemic, leading to increased research on its effectiveness and implementation in clinical practice. - Personalized and Precision Medicine:
There is a growing interest in personalized treatment approaches for respiratory diseases, focusing on biomarkers and genetic factors that influence treatment responses, especially in conditions like asthma and COPD. - Management of Drug-Resistant Tuberculosis:
Research on innovative strategies and therapies for managing drug-resistant tuberculosis has increased, reflecting the urgent need to address this global health challenge. - Environmental and Occupational Lung Diseases:
Emerging studies focus on the relationship between environmental exposures, such as air pollution, and lung diseases, emphasizing the need for public health interventions and awareness.
Declining or Waning
- Traditional Tuberculosis Studies:
While tuberculosis remains a significant health issue, there has been a noticeable decline in the number of studies solely focused on traditional tuberculosis treatments and diagnostics, as the field has shifted towards addressing multi-drug resistant strains and co-infections. - General Respiratory Infections:
Research on common respiratory infections, such as pneumonia caused by non-specific pathogens, appears to be waning, possibly due to a greater emphasis on more complex or emerging respiratory diseases such as COVID-19 and its sequelae. - Longitudinal Studies on Non-communicable Diseases:
There has been a reduction in longitudinal studies examining the long-term effects of non-communicable respiratory diseases, as the focus has shifted towards acute respiratory conditions and their immediate management. - Pediatric Respiratory Diseases:
The frequency of research focusing specifically on pediatric respiratory diseases has decreased, potentially due to a growing emphasis on adult respiratory conditions and the impact of COVID-19 on adult populations. - Traditional Clinical Trials for Established Therapies:
The journal has seen fewer articles reporting on traditional clinical trials for established therapies, as there is a shift towards exploring novel therapies and personalized medicine in respiratory care.
Similar Journals
Egyptian Journal of Bronchology
Advancing respiratory health through open access research.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
Zeitschrift fur Pneumologie
Transforming Insights into Clinical PracticeZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
RESPIRATION
Connecting Scholars to Transform Respiratory CareRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
THORAX
Fostering innovation in respiratory disease management.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
RESPIROLOGY
Innovating Insights in Respiratory ScienceRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
LUNG
Pioneering insights in respiratory health and clinical practice.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Exploring the frontiers of pulmonary medicine and patient care.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
Annals of the American Thoracic Society
Elevating clinical practice through impactful research and methodologies.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
Jornal Brasileiro de Pneumologia
Advancing respiratory health through innovative research.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
Thoracic Research and Practice
Elevating Patient Care in Pulmonary MedicineThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.